MELISSA LEE: Open Payments
NPI 1265812408 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 39 payments from 14 companies in 2025. Trend: 2023 $846 · 2024 $816 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 9 | $175 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $167 |
| Novo Nordisk Inc | 6 | $151 |
| Supernus Pharmaceuticals, Inc. | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| Astellas Pharma US Inc | 2 | $47 |
| MILLICENT US INC | 2 | $47 |
| Eisai Inc. | 1 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Baxter Healthcare | 1 | $26 |
Products named: ZURZUVAE, BIJUVA, Qelbree, Wegovy, Lynkuet, Veozah, MYFEMBREE, INTRAROSA.
Industry payments across TN — which companies pay providers there.
